Evidence-Based Management of MASLD: GRADE Evaluation of Pharmacological Therapies
Pharmaceuticals · 09.04.2026 · 19 (4) · 605
DOI: 10.3390/ph19040605 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pharmaceuticals, online erschienen am 09.04.2026. Verfasst von Eleni A Karavia und 7 weiteren Autor:innen. Beteiligte Einrichtung: Pharmacology Laboratory, Department of Medicine, University of Patras, Rio Achaias, 26500 Patras, Greece. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Hellenic Ministry of Education, Religious Affairs and Sports.
Abstract (Originalsprache)
Background/Objectives: Non-alcoholic fatty liver disease (NAFLD), recently redefined as metabolic dysfunction-associated steatotic liver disease (MASLD), represents a growing global health burden closely linked to obesity, insulin resistance, and dietary patterns. Despite intense drug-development efforts, effective and widely approved pharmacological therapies remain limited.
Methods
In this work, we systematically evaluated the quality of clinical evidence supporting currently proposed pharmacological treatments for MASLD/MASLD using the Grading of Recommendations Assessment, Development and Evaluation (GRADE) framework, focusing on phase III and IV clinical trials.
Results
Our analysis demonstrates that overall quality of evidence for most pharmacological agents ranges from very low to moderate, primarily due to imprecision and suspected publication bias.
Conclusions
Overall, our findings reinforce that, in the current therapeutic landscape, pharmacological therapies should be reserved for carefully selected patients and interpreted in the context of limited evidence certainty.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Pharmacology Laboratory, Department of Medicine, University of Patras, Rio Achaias, 26500 Patras, Greece.
- Adelco SA, 18346 Moschato, Greece.
- Laboratory of Industrial Food Technologies and Agricultural Industries Technologies, Chemical Engineering Department, Faculty of Engineering, Aristotle University of Thessaloniki, 54124 Thessaloniki, Greece.
ORCID-Profile: Eleni A Karavia, Andreas Pittaras, Ourania Andreopoulou, Patroklos Vareltzis, Kyriakos E Kypreos
Förderung
- Hellenic Ministry of Education, Religious Affairs and Sports
Zitieren
APA
Karavia, E. A., Pittaras, A., Andreopoulou, O., Hatziri, A., Makrydimitri, A., Anagnostopoulos, D., Vareltzis, P., & Kypreos, K. E. (2026). Evidence-Based Management of MASLD: GRADE Evaluation of Pharmacological Therapies. Pharmaceuticals, 19(4), 605. https://doi.org/10.3390/ph19040605
Vancouver
Karavia EA, Pittaras A, Andreopoulou O, Hatziri A, Makrydimitri A, Anagnostopoulos D, et al. Evidence-Based Management of MASLD: GRADE Evaluation of Pharmacological Therapies. Pharmaceuticals. 2026;19(4):605. doi:10.3390/ph19040605
BibTeX
@article{Karavia2026,
author = {Karavia, Eleni A and Pittaras, Andreas and Andreopoulou, Ourania and Hatziri, Aikaterini and Makrydimitri, Amalia and Anagnostopoulos, Dimitrios and Vareltzis, Patroklos and Kypreos, Kyriakos E},
title = {Evidence-Based Management of MASLD: GRADE Evaluation of Pharmacological Therapies},
journal = {Pharmaceuticals},
year = {2026},
volume = {19},
number = {4},
pages = {605},
doi = {10.3390/ph19040605}
}
EUVIMED